Navigation Links
Boston College's Amir Hoveyda receives Italy's Eni Award for Hydrocarbons Research
Date:6/17/2014

The 2014 Eni Scientific Award Commission cited Hoveyda's development of catalysts capable of synthesizing complex molecules with unique steric properties, or specifically distinct spatial arrangements of their main chain atoms. Hoveyda catalysts produce high purity compounds used in pharmaceuticals, fine chemicals and agrochemicals, with applications that extend into advanced materials and polymers. Some of the catalysts are being used in large-scale preparation of hydrocarbon-based therapeutics.

The connections to energy lie in the development of exceptionally efficient catalysts with high turnover ratios in a short amount of time, involving the use of non-precious and abundant elements that convert readily available renewable materials into highly valued molecules humans rely upon.

"Such catalysts do not demand heating or cooling, or the energy required to promote such reactions," Hoveyda said. "They do not require expending our non-renewable resources, which demand substantial time and energy to mine, and generate minimal amounts of environmentally harmful waste and reduce the energy costs of disposal. Catalysts and catalytic chemical reactions that depend on renewable resources and abundant elements are, without a doubt, a critical part of our future."

Sobell Professor of Chemistry Ilan Marek, of the Technion Israel Institute of Technology, said Hoveyda's work has had far-reaching implications within the field of hydrocarbons.

"I would be hard pressed to identify another individual whose contributions to the field of catalysis involving carbon-carbon bonds match Amir's in terms of quality and quantity," said Marek. "Throughout his career, Amir's work has been characterized by remarkable originality and far-sightedness. He has been a central figure in the definition of major fields as we known them asymmetric catalysis, metathesis, and carbenes to name a few. In each case, the field was revolutionized by his work."


'/>"/>
Contact: Ed Hayward
ed.hayward@bc.edu
617-552-4826
Boston College
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Boston Police Chief to Address Boston Marathon Bombings at IEEE Homeland Security Conference in Waltham, Mass., on 12 November
2. New findings on tree nuts and health presented at the Experimental Biology Meeting in Boston, Mass.
3. NIH grant funds Boston College research into illnesses afflicting people living with HIV
4. Michael Barnett of Boston College named Professor of the Year for Massachusetts
5. Synthetic biofilter wins through to the top Sweet 16 in Boston
6. Boston subway system to be used to test new sensors for biological agents
7. BUSM/VA Boston Healthcare System investigators identify new gene linked to PTSD
8. Boston Healthcare Associates Roundtable Explores Challenges and Opportunities Surrounding the Value of Big Data within the Life Sciences
9. Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27
10. Annual Drug Discovery Conferences Being Held in Boston MA, Spring 2012
11. Partnership enhances biology teaching at California community colleges
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Boston College's Amir Hoveyda receives Italy's Eni Award for Hydrocarbons Research
(Date:12/10/2014)... 2014     ...   Jifflenow, a leading ... for business-to-business (B2B) events, today announced a partnership ... near-field communication (NFC), Bluetooth low energy (BLE), and ... , Jifflenow will integrate its meeting ...
(Date:12/5/2014)... -- Tute Genomics, a leader in cloud-based solutions for genome ... led by UK-based Eurovestech. Peak Ventures and a number ... "We are at a pivotal time in ... seeks new approaches for the diagnosis, treatment and prevention ... and CEO of Tute Genomics. "One of the main ...
(Date:12/3/2014)...   Marvin Test Solutions , a trusted ... military, aerospace, and manufacturing organizations, today announced the ... TS-900 PXI semiconductor test platform . The TS-960 ... to customers at a fraction of the footprint ... "Our semiconductor customers asked for ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... Virology of the GSF National Research Center for ... Research Centres) the group is continuing to search for ... of a prion infection. In collaboration with colleagues from ... Heidelberg, the group used micro-array technologies micro-arrays ...
... plant cell biologist at UC Riverside has received a ... investigate how plant stem-cells maintain their identity and how ... According to G. Venugopala Reddy, the principal investigator of ... on plants, has potential to lead to better insights ...
... infant formula-- may reduce a babys susceptibility to rotavirus ... a University of Illinois study published in Septembers Journal ... diarrhea in infants, affecting virtually all children before age ... dehydration, doctors visits, and parents missing work to care ...
Cached Biology News:Prions and retroviruses -- an unholy alliance? 2UCR plant cell biologist to study how plant stem cells maintain and change their identity 2Soy isoflavone may inhibit common gastrointestinal illness in infants 2
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
(Date:12/17/2014)... 17, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a primary commercial focus on China ... a Type C meeting with the U.S. Food and ... held in February 2015.  During this meeting the Company ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  BrainStorm ... leading developer of adult stem cell technologies for neurodegenerative ... Ltd. was awarded a grant of approximately $1.1 million ... Chief Scientist (OCS).  This is the eighth year that ... the Office of the Chief Scientist, which is part ...
(Date:12/15/2014)... , Dec. 15, 2014  Ascendis Pharma A/S, ... technology to address significant unmet medical needs, today ... Phase 2 pediatric study to evaluate once-weekly TransCon ... or GHD.  This interim analysis consists of 25 ... enrollment in the study, completing all six months ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4
... Corp ., a non-profit development company that helps small businesses, ... technology businesses. , ,MDC said it has closed on loans ... off of Lucigen Corp. , and to BioSystem ... Contest. , ,C5-6 Technologies, which will develop enzymes used to ...
... series of articles on developing start-up companies in the technology or ... entity. , , Madison, Wis. - Now ... to the type of entity to use, you should have concerned ... people think of first. Income taxes depend upon the type of ...
... - Jim Rice, who has served as president and CEO ... the past year, will leave ITAWi after an agreed-upon transition ... organization announced. , ,ITAWi's Board of Director has begun ... will assume Rice's duties until a replacement is found. Rice ...
Cached Biology Technology:Early Stage: Step 6 - Taxes, taxes, taxes! 2Early Stage: Step 6 - Taxes, taxes, taxes! 3Early Stage: Step 6 - Taxes, taxes, taxes! 4Rice to leave Wisconsin technology association 2
Request Info...
... DuoSet ELISA Development kit contains the basic ... ELISAs to measure natural and recombinant rat ... serum. Each kit contains sufficient materials to ... provided that the following conditions are met: ...
Conjugation services for Antibodies, Proteins, Oligos, Peptides, Beads, bioconjugation, antibody-oligonucleotide, LNA peptide, LNA protein, LNA antibody, HRP, Alkaline phosphatase, phycoerythrin, FIT...
Blimp-1 (H-150)...
Biology Products: